Navigation Links
Sinobiopharma Reports a 141% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
Date:4/24/2009

NANTONG CITY, China, April 24 /PRNewswire-FirstCall/ -- Sinobiopharma, Inc. (OTC Bulletin Board: SNBP) ("Sinobiopharma" or, the "Company") is pleased to report financial highlights from the unaudited financial results for the nine month period ended February 28, 2009.

Financial highlights include:

  • Sales revenue increased to US $2,715,702 for the nine months ended February 28, 2009, from US $1,170,677 in the corresponding period ended February 29, 2008.
  • Gross profit increased to US $1,815,491, representing 67% of sales revenue, for the nine months ended February 28, 2009, from US $435,666, representing 37% of revenue, in the corresponding period ended February 29, 2008.
  • Net profit of the Company's wholly owned operating subsidiary, Dong Ying (Jiangsu) Pharmaceutical Co., Ltd., increased to US $851,324, representing 27% of sales revenue, for the nine months ended February 28, 2009, from - US $ 96,335 in the corresponding period ended February 29, 2008. However, the Company's overall net loss increased to US $1,622,692 for the nine months ended February 28, 2009, from US $444,672 for the nine months ended February 29, 2008, of which one of the main expenses affecting the results of operations was the stock-based compensation expense of US $1,944,750 reflecting the vesting of stock options granted by the Company having an exercise price of $1.80 per share.
  • Increase in sales volume and the improvement in gross profit percentage are both due to growth in sales of Cisatracurium Besylate, a skeletal muscle relaxant. Sales of this product increased to US $2,511,752 in the nine months ended February 28, 2009, from US $765,615 in the nine months ended February 29, 2008. At the same time, as volume has increased, cost of manufacturing Cisatracurium Besylate has decreased to 30% of its price for the nine months ended February 28, 2009, from 64% of its price f
    '/>"/>

SOURCE Sinobiopharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sinobiopharma Reports a 41% Increase in Revenues From Unaudited Financial Results for the 9 Month Period Ended February 28, 2009
2. Sinobiopharma, Inc. Appoints New Director of Marketing
3. Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier
4. Sinobiopharma Reports Financial Highlights for Six-Month Period Ending November 30, 2008
5. Anadys Pharmaceuticals Reports First Quarter 2009 Financial Results and Highlights
6. Cepheid Reports 2009 First Quarter Results
7. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
8. Health Robotics Reports Triple-Digit-Growth Across All Financial Metrics in Fiscal Year 2008
9. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market
10. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results with Financial Tables
11. Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009).... 30 Exiqon A/S (NASDAQ OMX Copenh...cal School ICCB-Longwood Screening Facility (ICCB-...ter of Excellence. ICCB-L supports investigators ...s and institutions, for high-throughput screening ...NAs are a novel class of small, non-coding RNA spe...
(Date:11/30/2009)...r 30 ApaTech, the rapidly growing,... growing,Biotech/Pharmaceutical/Medical Technology... Fast 500 for EMEA (Europe, Middle East and Africa...mpanies, five-year revenue growth,for which ApaTe... This,achievement places ApaTech 9th overall in th...
(Date:11/29/2009).... , The concept of confinement is one of the...example is that of quarks which bind together to f...m Helmholtz-Zentrum Berlin together with an intern...me an experimental realization and a proof of conf...system. , The concept of confinement states that...
(Date:11/27/2009)... Cromoz Inc., located in Research T...anotube-based cancer drug delivery system in Hyder...hich have functional groups on the walls that allo...d in partnership with the Indian Institute of Kanp...s a drug delivery vehicle with the ability to targ...
Breaking Biology Technology:Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4Spinons -- confined like quarks 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2
...ch Foundation has licensed the California immunol...esearch products using WARF,s stem cell patents, C...Tuesday. , ,Chemicon will have non-exclusive acces...hich were developed and patented through the Univ...sident of Chemicon, said the company would use the...
...f suburban Madison has received a Phase I Small Bu...00 from the National Cancer Institute. The grant i... for rapid quantification of protein activity, use... received a three-year Phase II SBIR grant for $2....mental Health Sciences. That grant was for the con...
...gement , a developer of databases and healthcare m...tomer relationship management solution has been im...h. , ,St. John used the CRM solution to promote i... Comprehensive Cancer Center, a 15-year partnershi...et research said the partnership had a lot of pote...
Other Biology Technology:WARF signs stem cell agreement with California firm 2
(Date:11/26/2009)...sharks are some of the Ocean,s most distinctive re...ve this strange head shape, says Michelle McComb ...son is the shark,s vision. ,Perhaps their visual f... says McComb, giving the sharks excellent stereovi...cComb, there were two schools of thought on this t...
(Date:11/26/2009)...rried out in eight European countries has shown th...isease pandemic could have a significant role in r...in the open access journal BMC Infectious Disease...days and weekends/holidays, finding that they were...m Hasselt and Antwerp University, Belgium, led a t...
(Date:11/26/2009)...cillin-resistant Staphylococcus Aureus ) and othe...as low-temperature plasma prototype devices have b...ling bactericidal cocktails. , Two prototype dev...ection of healthy skin (e.g. hands and feet) in ho...a lethal threat; and another to shoot bacteria-kil...
Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Fearless 3 Year Olds Might Be Tomorrows Criminals 61497 1Fearless 3 Year Olds Might Be Tomorrows Criminals 61497 2Fearless 3 Year Olds Might Be Tomorrows Criminals 61497 3Learn Proven Practices to Measure Align and Transform at SiriusDecisions Sales and Marketing Summit 2010 14865 1Learn Proven Practices to Measure Align and Transform at SiriusDecisions Sales and Marketing Summit 2010 14865 2Learn Proven Practices to Measure Align and Transform at SiriusDecisions Sales and Marketing Summit 2010 14865 3Sabalcore Computing Has Selected Scalable Informatics as Their Primary Storage Vendor 14863 1Sabalcore Computing Has Selected Scalable Informatics as Their Primary Storage Vendor 14863 2
...to specific sites on the neurotoxin protein, incre...effect. In some cases, the study noted, the activa...rteen-fold, the greatest increase in activation ev...wo-fold activation of a protease was referred to a...mes that act as cellular catalysts, breaking up pr...
...aunched on Tuesday 14 February at the Lions Cornea...t of hundreds of Victorians a year by extending th... transplant. , Thanks to the new facilities, LCDS ...vels (34C) for up to a whole month. Previously, co...transplanted within one week of the donation. , D...
... universities may lead to new directions in cancer...at a genetic switch involved in growth and develop...normal cells from becoming cancerous. , The findin...iology. Experiments were carried out by first auth...rking in the laboratories of Joel H. Rothman, a pr...
Other Biology News:Scientists develop a way to make the deadliest toxin known even more toxic 2Australian first to save sight 2Scientists discover a genetic switch that links animal growth and cancer 2
...ction Assay is an anchorage-independent growth ass...ngent assay for detecting malignant transformation...h carcinogens or carcinogen inhibitors) are cultur...or 21-28 days. Following this incubation period, ...
...implified procedure and streamlines the bisulfite ...sed on the three step reaction that takes place be... is converted into uracil. The EZ DNA Methylation ...eliminates several precipitation steps and provide...
...ntended for laboratory research use only. The ind...malin and embedded in paraffin. Tissue identifica...ologists. Tissue cores were removed from their pa...araffin block, in an array pattern, using Chemicon...
Odyssey Infrared Imaging System from LI-COR Biosciences
Biology Products: